Half Year 2026 Nova Eye Medical Ltd Earnings Presentation Transcript
Good morning, everyone. And once again, thank you for joining us. Welcome to the Nova Eye Medical Investor webinar covering our half-year results for the six months ended 31 December 2025, along with an update that we put out this morning on our recent EU MDR certification. My name is Mark Flynn. I look after Investor Relations at Nova Eye.
Today, as usual, our Managing Director, Thomas Spurling, will walk us through the key financial outcomes from the half, the continued momentum we have in the US, margin and EBITDA progression, cash flow and obviously, the outlook for the second half for FY '26.
We'll cover the strategic importance of securing that EU MDR certification, which is a big and major
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
